Nicole Bartelt
Nurse Practitioner · Waukesha, WINPI 1841531571
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.9%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Axsome Therapeutics, Inc. at 56.6% of the total. 2025 is the largest year on record at $45,629, more than ten times the $816 reported in 2021. Among nurse practitioner clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,021 payments — averaging $83.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$48K
- Otsuka America Pharmaceutical, Inc.$27K
- Lundbeck LLC$2K
- AbbVie$2K
- Corium, LLC$1K
- Supernus Pharmaceuticals, Inc.$824
- plus $4K from 23 others
What the payments were for
- Consulting fees$12,12514%
- Speaking & faculty fees$50,95860%
- Travel & lodging$5,5967%
- Food & beverage$16,26819%
- Education$1500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 188 | $48,171 |
| Otsuka America Pharmaceutical, Inc. | 180 | $27,180 |
| Lundbeck LLC | 144 | $1,980 |
| AbbVie | 124 | $1,667 |
| Corium, LLC | 72 | $1,005 |
| Supernus Pharmaceuticals, Inc. | 51 | $824 |
| Takeda Pharmaceuticals U.S.A., Inc. | 62 | $782 |
| Vanda Pharmaceuticals Inc. | 44 | $547 |
| Neurocrine Biosciences, Inc. | 20 | $372 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $358 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 6 | $336 |
| Harmony Biosciences LLC | 16 | $264 |
| Ironshore Pharmaceuticals Inc. | 17 | $254 |
| Collegium Pharmaceutical, Inc. | 21 | $225 |
| Idorsia Pharmaceuticals US Inc | 11 | $221 |
| Almatica Pharma LLC | 6 | $126 |
| Tris Pharma Inc | 7 | $124 |
| Adlon Therapeutics L.p. | 7 | $118 |
| Teva Pharmaceuticals USA, Inc. | 6 | $101 |
| Neos Therapeutics, LP | 5 | $85 |
| Sunovion Pharmaceuticals Inc. | 6 | $78 |
| Alkermes, Inc. | 3 | $71 |
| Bausch Health US, LLC | 4 | $70 |
| Avanir Pharmaceuticals, Inc. | 2 | $41 |
| Noven Therapeutics, LLC | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| Indivior Inc. | 1 | $21 |
| Sage Therapeutics, LLC | 1 | $20 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$85,096 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AuvelityDextromethorphan Hbr/Bupropion | 18 | $20,613 |
| Aripiprazole | 30 | $1,759 |
| Quetiapine Fumarate | 76 | $1,373 |
| Divalproex Sodium ErDivalproex Sodium | 36 | $979 |
| Lamotrigine | 55 | $830 |
| Duloxetine Hcl | 28 | $811 |
| Hydroxyzine Hcl | 23 | $738 |
| Fluvoxamine Maleate | 15 | $707 |
| Buspirone Hcl | 40 | $699 |
| Sertraline Hcl | 67 | $590 |
| Gabapentin | 29 | $526 |
| Bupropion XlBupropion Hcl | 18 | $513 |
| Prazosin Hcl | 11 | $491 |
| Trazodone Hcl | 38 | $474 |
| Mirtazapine | 25 | $326 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Axsome Therapeutics, Inc.Auvelity | $48,171 | $20,61318 claims |
| Almatica Pharma LLCSertraline Hcl | $126 | $59067 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.
Other nurse practitioner in Waukesha
- Jodi StrongStevens Point$246K
- Jo Ellen FrawleyPrairie du Sac$194K
- Trisha WilcoxMilwaukee$174K
- Sally BowaGreen Bay$117K
- Christina SauldMilwaukee$111K
- Melissa WendellWausau$98K
- Kari FisherPrairie du Sac$57K
- Roxanne RadichAppleton$54K
- Kelly FlugaurMilwaukee$38K
- Christa ScheunemannWest Bend$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.